Search Results

There are 3354071 results for: content related to: Reply

  1. Immunogenicity of interferon-β in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration

    Annals of Neurology

    Volume 48, Issue 5, November 2000, Pages: 706–712, Christian Ross, Katja Maria Clemmesen, Morten Svenson, Per Soelberg Sørensen, Nils Koch-Henriksen, Gunhild Lange Skovgaard and Klaus Bendtzen

    Version of Record online : 4 APR 2001, DOI: 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.0.CO;2-V

  2. Interferon in relapsing-remitting multiple sclerosis

    Intervention Review

    The Cochrane Library

    George PA Rice, Barbara Incorvaia, Luca M. Munari, George Ebers, Chris Polman, Roberto D'Amico, Elena Parmelli and Graziella Filippini

    Published Online : 23 OCT 2001, DOI: 10.1002/14651858.CD002002

  3. Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis

    Annals of Neurology

    Volume 48, Issue 6, December 2000, Pages: 885–892, Jill S. Fischer, Roger L. Priore, Lawrence D. Jacobs, Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon, John R. Richert, Andres M. Salazar, Donald E. Goodkin, Carl V. Granger, Jack H. Simon, Jordan H. Grafman, Muriel D. Lezak, Kathleen M. O'Reilly Hovey, Katherine Kawczak Perkins, Danielle Barilla-Clark, Mark Schacter, David W. Shucard, Anna L. Davidson, Karl E. Wende, Dennis N. Bourdette and Mariska F. Kooijmans-Coutinho

    Version of Record online : 23 MAR 2001, DOI: 10.1002/1531-8249(200012)48:6<885::AID-ANA9>3.0.CO;2-1

  4. A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity

    Annals of Neurology

    Volume 78, Issue 1, July 2015, Pages: 115–127, Federica Esposito, Melissa Sorosina, Linda Ottoboni, Elaine T. Lim, Joseph M. Replogle, Towfique Raj, Paola Brambilla, Giuseppe Liberatore, Clara Guaschino, Marzia Romeo, Thomas Pertel, James M. Stankiewicz, Vittorio Martinelli, Mariaemma Rodegher, Howard L. Weiner, David Brassat, Christophe Benoist, Nikolaos A. Patsopoulos, Giancarlo Comi, Wassim Elyaman, Filippo Martinelli Boneschi and Philip L. De Jager

    Version of Record online : 14 MAY 2015, DOI: 10.1002/ana.24429

  5. IFNβ impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation

    Journal of Cellular Physiology

    Volume 227, Issue 6, June 2012, Pages: 2668–2676, V.J. Woeckel, M. Eijken, J. van de Peppel, H. Chiba, B.C.J. van der Eerden and J.P.T.M. van Leeuwen

    Version of Record online : 24 FEB 2012, DOI: 10.1002/jcp.23009

  6. Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

    European Journal of Neurology

    Volume 19, Issue 6, June 2012, Pages: 899–904, J. Río, M. Tintoré, J. Sastre-Garriga, C. Nos, J. Castilló, C. Tur, M. Comabella and X. Montalban

    Version of Record online : 31 JAN 2012, DOI: 10.1111/j.1468-1331.2011.03648.x

  7. Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta

    Annals of Neurology

    Volume 73, Issue 1, January 2013, Pages: 95–103, Robert A. Bermel, Xiaojun You, Pamela Foulds, Robert Hyde, Jack H. Simon, Elizabeth Fisher and Richard A. Rudick

    Version of Record online : 1 FEB 2013, DOI: 10.1002/ana.23758

  8. Evidence of vitamin D and interferon-β cross-talk in human osteoblasts with 1α,25-dihydroxyvitamin D3 being dominant over interferon-β in stimulating mineralization

    Journal of Cellular Physiology

    Volume 227, Issue 9, September 2012, Pages: 3258–3266, V.J. Woeckel, M. Koedam, J. van de Peppel, H. Chiba, B.C.J. van der Eerden and J.P.T.M. van Leeuwen

    Version of Record online : 17 MAY 2012, DOI: 10.1002/jcp.24020

  9. Importance of magnetic resonance imaging and gadolinium enhancement

    Annals of Neurology

    Volume 40, Issue 6, December 1996, Pages: 951–952, D. W. Paty and D. K. Li

    Version of Record online : 16 OCT 2004, DOI: 10.1002/ana.410400632

  10. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis

    European Journal of Neurology

    Volume 17, Issue 5, May 2010, Pages: 672–676, A. Uzawa, M. Mori, S. Hayakawa, S. Masuda and S. Kuwabara

    Version of Record online : 21 DEC 2009, DOI: 10.1111/j.1468-1331.2009.02897.x

  11. You have free access to this content
    Amelioration of collagen-induced arthritis and suppression of interferon-γ, interleukin-12, and tumor necrosis factor α production by interferon-β gene therapy

    Arthritis & Rheumatism

    Volume 42, Issue 1, January 1999, Pages: 90–99, Kostas A. Triantaphyllopoulos, Richard O. Williams, Hitakshi Tailor and Yuti Chernajovsky

    Version of Record online : 22 MAY 2001, DOI: 10.1002/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A

  12. Contrasting responses to interferon β-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

    Annals of Neurology

    Volume 48, Issue 3, September 2000, Pages: 313–322, A. H. H. Van Boxel-Dezaire, S. C. J. Van Trigt-Hoff, J. Killestein, H. M. Schrijver, J. C. Van Houwelingen, C. H. Polman and L. Nagelkerken

    Version of Record online : 15 MAR 2001, DOI: 10.1002/1531-8249(200009)48:3<313::AID-ANA5>3.0.CO;2-9

  13. Association between beta-interferon exposure and hospital events in multiple sclerosis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 11, November 2014, Pages: 1213–1222, Charity Evans, Feng Zhu, Elaine Kingwell, Afsaneh Shirani, Mia L. van der Kop, John Petkau, Paul Gustafson, Yinshan Zhao, Joel Oger and Helen Tremlett

    Version of Record online : 21 JUN 2014, DOI: 10.1002/pds.3667

  14. Interferon beta-1b treatment in patients with relapsing–remitting multiple sclerosis under a standardized protocol in Spain

    Acta Neurologica Scandinavica

    Volume 102, Issue 4, October 2000, Pages: 209–217, T. Arbizu, J. C. Álvarez-Cermeño, G. Decap, O. Fernández, D. F. Uría, A. García Merino, G. Izquierdo and X. Montalbán

    Version of Record online : 24 DEC 2001, DOI: 10.1034/j.1600-0404.2000.102004209.x

  15. You have full text access to this OnlineOpen article
    A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 4, Issue 5, May 2015, Pages: 295–304, A Gulati, F Bagnato, P Villoslada and N Velez de Mendizabal

    Version of Record online : 24 APR 2015, DOI: 10.1002/psp4.36

  16. You have free access to this content
    The effects of interferon-β treatment on synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 43, Issue 2, February 2000, Pages: 270–274, Tom J. M. Smeets, Jean M. Dayer, Maarten C. Kraan, Johannes Versendaal, Rachel Chicheportiche, Ferdinand C. Breedveld and Paul P. Tak

    Version of Record online : 2 APR 2001, DOI: 10.1002/1529-0131(200002)43:2<270::AID-ANR5>3.0.CO;2-H

  17. You have free access to this content
    Interferon-β1A–induced polyarthritis in a patient with the HLA–DRB1*0404 allele

    Arthritis & Rheumatism

    Volume 42, Issue 3, March 1999, Pages: 569–573, Marc C. Levesque, Frances E. Ward, Douglas R. Jeffery and J. Brice Weinberg

    Version of Record online : 22 MAY 2001, DOI: 10.1002/1529-0131(199904)42:3<569::AID-ANR23>3.0.CO;2-M

  18. You have full text access to this OnlineOpen article
    Beta-interferon exposure and onset of secondary progressive multiple sclerosis

    European Journal of Neurology

    Volume 22, Issue 6, June 2015, Pages: 990–1000, T. Zhang, A. Shirani, Y. Zhao, M. E. Karim, P. Gustafson, J. Petkau, C. Evans, E. Kingwell, M. van der Kop, F. Zhu, J. Oger, H. Tremlett and BC MS Clinic Neurologists

    Version of Record online : 6 APR 2015, DOI: 10.1111/ene.12698

  19. One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

    European Journal of Neurology

    Volume 16, Issue 11, November 2009, Pages: 1202–1209, L. Prosperini, V. Gallo, N. Petsas, G. Borriello and C. Pozzilli

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1468-1331.2009.02708.x

  20. Current Disease-Modifying Treatment of Multiple Sclerosis

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 78, Issue 2, March/April 2011, Pages: 161–175, Joy Derwenskus

    Version of Record online : 21 MAR 2011, DOI: 10.1002/msj.20239